![](https://investorshub.advfn.com/uicon/632715.png?cb=1505107773)
Tuesday, April 18, 2023 9:24:39 PM
when were the MIA regulations to permit global exports announced and made effective?
1 July 2021? I haven’t seen any new regulations, but I’m not sure if this only applies to starting materials for ATMPs, or also includes the finished product.
Importing and exporting human tissues and cells if you are an establishment based in Great Britain
If you are an establishment based in Great Britain (GB) that imports or exports human tissues or cells for human application between GB and a country in the European Economic Area (EEA), you may need an HTA licence that covers these activities.
This requirement came into force on 1 July 2021.
Human application means using human tissues or cells on or in a human recipient. This includes use in extracorporeal applications. It excludes the use of an autologous graft within the same surgical procedure.
The new licensing requirements also apply to the import and export of tissues and cells that form the starting material for Advanced Therapy Medicinal Products (ATMPs).
If you think these changes apply to you, please contact us to discuss your activities.
Who is affected
New import or export licences
https://www.hta.gov.uk/guidance-professionals/uk-transition-guidance/importing
Apply for a licence
See our Human Application sector licence forms for import and export
APPLY NOW
LAST UPDATED ON 13 SEP 2021
New import or export licences
The HTA-related licensing changes introduced at the end of the UK Transition Period affect some establishments that previously did not require an HTA licence for importing or exporting human tissues and cells for human application.
Examples of human application include:
* the use of bone, pericardium, and dermal tissue products in dentistry;
* bone products used for orthopaedic treatment;
* amnion tissue products used as barriers in wound healing;
* skin grafts used to replace damaged skin tissue; and
* corneal grafts used in ocular surgery.
Please note that the above list is not exhaustive and other activities may be affected.
If you import tissues and cells from the EEA for human application or export such material to the EEA for this purpose, you will need an HTA licence to carry out this activity.
This requirement came into force on 1 July 2021.
To apply for a new HTA licence, please visit our Human Application sector licence form page. Alternatively, please contact us so that we can understand your activities and provide you with advice.
https://www.hta.gov.uk/guidance-professionals/uk-transition-guidance/importing/new-import-or-export-licences
Human Application sector licence forms
Under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended) (the Q&S Regulations), the HTA licenses and inspects establishments that undertake the procurement, testing, processing, storage, distribution, import and export of tissues and cells for human application.
More information can be found on our Licensing under the Human Tissue (Quality and Safety for Human Application) Regulations, 2007 (as amended) (the Q&S Regulations) page.
Information on licence fees can be found on our Licence fees and payments page.
Licensing requirements following the end of the Brexit transition period
The United Kingdom (UK) has left the European Union (EU) single market and customs union, which has resulted in regulatory changes within the UK.
These changes require some Human Application (HA) sector establishments to update their licences in order to start, or continue, to import or export tissues and cells for human application from/to the European Economic Area (EEA).
The changes also apply to the import and export of tissues and cells that form the starting material for Advanced Therapy Medicinal Products (ATMPs).
You can read more about the regulatory changes and the new licence requirements on our UK Transition guidance pages.
Licence application and variation forms
The HTA has issued new forms to help establishments apply for a licence or update (vary) an existing licence.
Whilst the forms all follow the same basic structure, the content has been adjusted to reflect the amount of information that needs to be submitted to support the licence application or variation across a range of licensing scenarios.
Please use the tools below to identify the form(s) that you need to complete. If you have any HTA licensing questions, please email: licensing@hta.gov.uk so that we can provide you with guidance and the relevant application forms.
Establishments based in Great Britain (GB)
Click here to see Human Application sector licence forms if you are an establishment based in GB
GB LICENCE FORMS
https://www.hta.gov.uk/guidance-professionals/licensing/human-application-sector
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM